Top Markets
#1 Seeker Seeker +121.00%
#2 AI XOVIA AI XOVIA +117.73%
#3 MowCat MowCat +108.08%
#4 Helium Helium +87.29%
#5 Pons Pons +46.79%
#6 UnifAI Network UnifAI Network +34.22%
#7 Zora Zora +31.44%
#8 Bounce Bounce +21.20%
#9 Zylo Ecosystem Zylo Ecosystem +20.84%
#10 Tensor Tensor +20.29%
Coin of the day
Seeker Seeker
Settings
Language
ENGLISH
Currency
USD
Theme
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

300534
Rank in Stocks #11766
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a... Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.
Share Price
$2.18
Last synced: 2026-08-28
Market Cap
$661.58M
Change (1 day)
-13.01%
Change (1 year)
52.92%
Country
CN
Trade Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

Category

Healthcare
Operating Margin for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)
Operating Margin as of 2026 TTM: 0.00%
According to Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00% -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00% -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00% -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00% -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
22.93% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.